Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)
Status: RECRUITING
Study type: OBSERVATIONAL
Conditions: Pleural Effusion, Malignant|Ascites, Malignant|Carcinoma|Carcinoma, Hepatocellular|Carcinoma, Renal Cell|Carcinoma, Renal|Carcinoma, Small Cell|Carcinoma, Non-Small-Cell Lung|Carcinoma, Pancreatic Ductal|Carcinoma, Neuroendocrine|Carcinoma, Thymic|Carcinoma, Pancreatic|Carcinoma Breast|Carcinoma, Ovarian|Carcinoma Bladder|Carcinoma of Unknown Primary|Carcinoma of the Head and Neck|Carcinoma of the Oropharynx|Carcinoma of the Larynx|Carcinoma of the Bladder|Carcinoma of Esophagus|Carcinoma of the Nasopharynx|Carcinoma of the Penis|Carcinoma of the Cervix|Carcinoma of the Anus|Carcinoma of the Vulva|Carcinoma of the Appendix|Carcinoma of the Oral Cavity|Cholangiocarcinoma|Melanoma|Mesothelioma|Pancreatic Cancer
Sponsor: Travera Inc
Collaborators: xCures